SEC Form 4 · accession 0001209191-17-052585
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Falvey
Officer — EVP, CFO & Treasurer
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (right to buy)F1 | $10.60 | Sep 11, 2017 | A | 125,000 | A | — | Sep 10, 2027 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1This option was granted on September 11, 2017. The shares underlying this option vest as to 25% of the shares on September 11, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter.